Introduction
Managing blood sugar levels around mealtimes is an important part of diabetes care. Many people with diabetes require rapid-acting insulin to help control the rise in blood glucose that occurs after eating as part of an individualized treatment plan.
Lyumjev is an ultra-rapid-acting insulin that is administered at mealtime to improve glycemic control in adults and pediatric patients with diabetes mellitus. Its specialized formulation allows insulin to be absorbed more quickly than traditional insulin lispro formulations, helping reduce post-meal blood glucose excursions.
Because Lyumjev is a brand-name prescription insulin available in multiple delivery systems, treatment costs can vary. Many people searching for a Lyumjev patient assistance program are looking for ways to reduce their prescription expenses.
Prescription Hope provides qualified patients with access to affordable medications such as Lyumjev by advocating on patients’ behalf with patient assistance programs.
What Is the Lyumjev Patient Assistance Program?
Understanding Lyumjev Prescription Assistance
Some patients may have found the Lyumjev patient assistance program while researching where to find Lyumjev financial assistance. But what is a patient assistance program, and how does it provide help paying for Lyumjev?
Some pharmaceutical manufacturers have recognized that the cost of name-brand medications is difficult for struggling Americans to pay. To help their patients with their financial strain, manufacturers will launch patient assistance programs that allow qualified patients to receive their needed name-brand medications at a lower cost than the going rate.
Unfortunately, some patients reject financial assistance because patient assistance programs often require extensive administrative work to obtain approval. This includes paperwork and communication with healthcare providers and the manufacturer. This deters patients who may lack the time to commit or are worried about feeling overwhelmed by the process.
Prescription Hope can help.
How Expert Advocates Help Make Lyumjev More Affordable
Personalized Medication Assistance
Prescription Hope’s Lyumjev enrollment assistance helps qualified patients access their needed name-brand medication at a lower cost than retail price.
Our team of prescription assistance specialists offers diabetes medication support in both the short-term Lyumjev application help and the long-term assistance in maintaining access to the program. Some ways we work to support you through the process include taking care of forms, documents, and signatures, communication with healthcare providers, coordinating with manufacturers, and more.
Ongoing Patient Support
Our team of patient advocates assist you with your application process, and offers long-term medication assistance throughout the course of your treatment continuity. Some of the ways we continue to help support you include refill scheduling, document updates, yearly renewals, program monitoring, and more.
Lyumjev Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Navigating Diabetes Treatment Costs
While diabetes can be a difficult condition to maintain, accessing Lyumjev cost assistance doesn’t have to be. Diabetes medication affordability is just one of the ways Prescription Hope helps our qualified patients.
No matter the brand-name medication, qualified patients gain access to all our prescription cost help at an easy monthly rate of $70.00 per month, per medication. There are no hassles, hidden fees, or add-ons with this monthly cost.
Patients who don’t meet the qualifications may still gain help from our team. We will help you find other ways to save money on your name-brand medication, such as substitute medications, discount cards, and coupons. If we can’t help you save money, you pay nothing!
Lyumjev Patient Assistance Eligibility
General Eligibility Requirements
There are different requirements for each patient assistance program. To know who qualifies for Lyumjev assistance, enroll with Prescription Hope.
All patient assistance programs have different requirements in some categories, such as:
Income: Patient income criteria are determined by each program.
Insurance: Patient insurance coverage status is also determined by each program.
Prescription: Qualified patients must have a valid prescription for their intended medication.
U.S. Residency: Qualified patients must be a legal resident of the U.S.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Are you looking to enroll in Lyumjev assistance? Do you need help with the Lyumjev application process? Prescription Hope can fill your need for prescription support services in 6 easy steps:
- Submit Information: Our online enrollment form can be completed in a few minutes.
- Advocate Contact: After we receive your enrollment form, our team of patient advocates will reach out to you in 1-2 business days.
- Document Collection: Our team will collect any needed documents after your prequalification.
- Provider Coordination: We will also coordinate with your healthcare provider to obtain any signatures needed.
- Program Submission: We then put everything in order and submit your application on your behalf, all while continuing to organize the details with the pharmaceutical manufacturer.
- Medication Delivery: After approval, patients typically receive their medication withinn 2 weeks. Shipments arrive at their front door or doctor’s office.
Understanding Lyumjev
How Lyumjev Works
Lyumjev contains insulin lispro-aabc, an ultra-rapid-acting insulin analog that lowers blood glucose by:
- Promoting the uptake of glucose into muscle and fat cells
- Reducing glucose production by the liver
- Inhibiting the breakdown of fat and protein
Lyumjev also contains treprostinil and citrate as formulation excipients that accelerate the absorption of insulin lispro after injection, allowing earlier insulin action and improved postprandial glucose control compared with traditional insulin lispro formulations.
What Conditions Does Lyumjev Treat?
Lyumjev is FDA-approved to improve glycemic control in adults and pediatric patients with diabetes mellitus.
Lyumjev is an ultra-rapid-acting insulin administered at mealtime to help control blood glucose spikes associated with eating. It is intended for use as part of an individualized diabetes treatment plan.
Benefits of Treatment
For appropriate patients with diabetes, Lyumjev may:
- Improve blood glucose control at mealtime
- Better reduce post-meal (postprandial) blood glucose excursions
- Provide earlier insulin action than traditional insulin lispro formulations
- Be administered immediately before meals or within 20 minutes after beginning a meal
- Be used with insulin pumps and multiple daily injection regimens in appropriate patients
Individual insulin doses should always be tailored by a healthcare provider based on blood glucose monitoring and patient-specific needs.
Important Safety Information and Side Effects
Lyumjev does not carry an FDA Boxed Warning.
Contraindications
Lyumjev is contraindicated:
- During episodes of hypoglycemia
- In patients with serious hypersensitivity to insulin lispro or any of the product’s excipients
The most commonly reported side effects include:
- Hypoglycemia (low blood sugar)
- Injection site reactions
- Injection site pain
- Lipodystrophy
- Weight increase
- Swelling of the hands or feet (peripheral edema)
- Rash
- Pruritus (itching)
- Nasopharyngitis (reported in some pediatric patients)
Patients using continuous subcutaneous insulin infusion (CSII) pumps may also experience infusion site reactions.
Patients should discuss the following risks with their healthcare provider:
- Severe hypoglycemia
- Hypersensitivity reactions, including anaphylaxis
- Hypokalemia (low potassium levels)
- Hyperglycemia or diabetic ketoacidosis resulting from insulin pump malfunction
- Medication errors caused by confusing different insulin products
- Fluid retention and heart failure when used with thiazolidinediones (TZDs)
- Lipodystrophy and localized cutaneous amyloidosis at injection sites
- Hyperglycemia associated with changes in insulin regimen
- The need for close blood glucose monitoring whenever insulin therapy is initiated or adjusted
Patients should never change their insulin regimen without consulting their healthcare provider.
Available data have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes with insulin lispro. Good blood glucose control during pregnancy is important to reduce diabetes-related risks. Insulin requirements may change during pregnancy and after delivery, and patients who are pregnant or planning to become pregnant should work closely with their healthcare provider to manage insulin therapy.
Insulin is present in human breast milk, and available data do not suggest adverse effects in breastfed infants. Insulin requirements may change during breastfeeding, and dosage adjustments may be needed.
Lyumjev may interact with:
- Other antidiabetic medications, including GLP-1 receptor agonists and SGLT2 inhibitors
- Beta-blockers
- Sympatholytic medications
- Corticosteroids
- Diuretics
- Monoamine oxidase inhibitors (MAOIs)
- ACE inhibitors
- Alcohol
- Thiazolidinediones (TZDs)
Patients should inform their healthcare provider about all prescription medications, over-the-counter medicines, vitamins, and herbal supplements before beginning treatment.
Lyumjev is administered by subcutaneous injection and is available as a KwikPen®, Tempo Pen®, Junior KwikPen®, prefilled cartridge, and vial. It may also be administered by continuous subcutaneous insulin infusion (CSII) using compatible insulin pumps. Lyumjev should be administered at the start of a meal or within 20 minutes after beginning a meal. Injection sites should be rotated to reduce the risk of lipodystrophy and localized cutaneous amyloidosis. Patients should never share Lyumjev pens, cartridges, or reusable pen devices, even if the needle has been changed.
Access to Multiple Medications
Support Beyond Lyumjev
Some patients needing diabetes medication assistance or insulin assistance programs also search for other means of prescription medication access. Thankfully, Prescription Hope has access to multiple medication assistance programs. This means that no matter how many medications a qualified patient needs, Prescription Hope can help for the same low rate of $70.00 per month, per medication.
Why Choose Prescription Hope
Patient-Focused Medication Support
For 20 years, Prescription Hope has offered patient-centered prescription help to qualified patients over America. We are proud to offer Lyumjev assistance through Prescription Hope.
Simplified Access to Prescription Medications
Prescription Hope offers all patient assistance services at the same low rate of $70.00 per month, per medication. There are no hidden fees, long contracts, hidden costs, or even costs for your medication.
Ongoing Prescription Assistance
In addition to helping you with your application to a patient assistance program, we also offer long-term medication support, including refill scheduling, yearly renewals, document updates, program monitoring, and more.
Network Access
Our network includes hundreds of name-brand medications and the patient assistance programs that go with them.
If you need Lyumjev and you don’t know how you’re going to pay for it, enroll with Prescription Hope to see how we can help you save money today!